PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut

PhaseWell Research ("PhaseWell"), a multisite clinical research company, today announced the strategic acquisition of Chase ...

Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development

"New BCC Research analysis projects 13.7% CAGR, driven by regulatory momentum, AI integration and the push for greater patient diversity in clinical research"Boston, March 19, 2026 (GLOBE NEWSWIRE) -- ...

Irish cancer patients missing out on life-saving trials due to funding disparity

Cancer patients have to travel long distances to participate in potentially life-saving clinical trials because of shortages ...

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

The MarketWatch News Department was not involved in the creation of this content. MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical ...
Applied Clinical Trials Online

Patient Engagement Practices Informing Strategies to Address Vaccine Hesitancy

Vaccine hesitancy is widely recognized as one of the most significant public health problems of the 21 st Century. The World Health Organization (WHO) identifies vaccine hesitancy ...

Obesity drug tests upended by placebo patients leaving early

The companies developing new weight-loss medicines have a problem: the balance of power has shifted, and patients are bailing ...
PharmiWeb

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Conducting Sham Clinical ...

Alert: Claims Focus on Alleged Misrepresentations About Clinical Trial Integrity and Drug SafetyNEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP reminds purchasers of Soleno Therapeutics, Inc. (NASDAQ ...
Medscape

How to Build Trust When Patients Believe Misinformation

Too frequently, clinicians think all they need to say is, ‘I know better,’ and that’s not what patients need to hear,” said Christy J.W. Ledford, PhD, communication scientist at the Medical College of ...

‘Thank God they’re still alive’: Kaiser therapists claim its new screening system puts patients at higher risk by delaying their care

Kaiser pushed back on striking workers’ claims and AI fears, saying it delivers ‘timely, high-quality care to meet members’ needs’ ...

Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program

Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the signing of an agreement with ...
TMCnet

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADE ...